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ABSTRACT
Background: There is growing interest in probiotics such as lactic acid bacteria (LAB), not only for treatment
of T helper type (Th) 1-mediated diseases but also for Th2-mediated diseases, including allergic diseases,
since lactic acid bacteria may be able to modulate the Th1Th2 balance, in addition to having an immunomodu-
lative effect through induction of Th1 bias.
Methods: The effect of oral administration of heat-killed Lactobacillus acidophilus Strain L-92 (L-92) on oval-
bumin (OVA)-specific immunoglobulin (Ig)E production was investigated in BALBc mice. L-92 was orally ad-
ministered to mice for 8 weeks from 2 weeks after initiation of OVA-immunization. Patterns of cytokine and Ig
production in splenocytes and cells from Peyer’s patches (PPs) from these mice were examined after restimu-
lation with OVA in vitro.
Results: L-92 significantly suppressed serum OVA-specific IgE levels for a long period. Cytokines such as in-
terferon (IFN)-γ, interleukin (IL)-4 and IL-10 and Igs such as total IgE and OVA-specific IgE were produced at
significantly lower levels by splenocytes of L-92-treated mice, compared with those of control mice. In contrast,
transforming growth factor (TGF)-β and IgA levels produced by PPs from L-92-treated mice were significantly
higher than in those from control mice.
Conclusions: Oral L-92 administration regulated both Th1 and Th2 cytokine responses, suppressed serum
OVA-specific IgE, and induced TGF-β production in PPs. TGF-β is known to be associated with activation of
regulatory T (Treg) cells. These data suggest that LAB may have immunomodulative effect by Treg cells via
TGF-β activity.
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INTRODUCTION
Probiotics may establish T helper type (Th) 1 bias
and predominance of regulatory T (Treg) cells
through changes in the composition of intestinal mi-
croflora in a host, due to effects or direct action on
gut-associated lymphoid tissue (GALT). Recent stud-
ies have also documented a relationship between pro-
biotic induction of intestinal microorganisms and re-
sistance to development of allergy.1-3 Several strains
of Lactobacillus, including L. casei strain Shirota,4 L.
plantarum strain L-1375 and L. acidophilus strain L-92
(L-92)6 have been reported as probiotics that modify
antigen-specific serum immunoglobulin (Ig) E levels
in animal models. These results suggest the possible
usage of such lactic acid bacteria (LAB) in preventing
atopic diseases. Little is known, however, about the
exact mechanisms underlying the suppressive and
immunomodulative effects of LAB.
In contrast to their propensity to counteract aller-
gic development, LAB also exert inhibitory effects on
the development of Th1-mediated diseases, including
colitis and diabetes in animals and humans,7-14 sug-
gesting that they may modulate immunity through a
mechanism that does not involve polarization of the
immune response toward Th1. One possibility is that
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Fig. 1 Experimental schedule 1. Immunization with OVA and oral admini-
stration of L-92 in mice, (and measurement of cytokine (IFN-γ, IL-4, IL-10 
and TGF-β) and Ig (total IgE, OVA-specific IgE and total IgA) production 
from splenocytes and cels of PPs in the L92-treated mice.) Sham mice 
were intraperitonealy injected with 0.1 ml sterile 0.9% saline only in weeks 
0, 2, 4, 6 and 8 and also fed daily with 200 μl of sterile 0.9% saline.
0 2 4 6 8 10
Splenocyte,
Peyer’s patch
Week
BALB/c
Mice
i.p.1 μg OVA + 1 mg Al(OH)3/mouse
every two weeks
p.o. administration of L-92
Cytokine production
IFN-γ, L-4, IL-10, TGF-β
Immunoglobulin production
Total-IgE, OVA specific-IgE, 
Total-IgA
Treg cells play an important role in regulating the
Th1Th2 imbalance underlying the immunomodula-
tive effects of LAB. In support of this hypothesis,
Ohno et al. showed that the suppressive effect of spe-
cific IgE production of Bifidobacterium bifidum G9-1
(BBG9-1) in ovalbumin (OVA)-immunized mice is
due to reduction of IgE production via an interferon
(IFN)-γ-independent mechanism mediated by Treg
cells.15 Hence, the immunomodulative effects of LAB
may not only be due to induction of Th1 bias, as re-
ported to date, but may also occur through modula-
tion of the imbalance of Th1 and Th2 cells.
The presence of two kinds of CD4 + Treg cells, T
regulatory type 1 (TR1) cells and T helper type 3 (TH3)
cells, has recently been shown in mucosal immuniza-
tion. Akbari et al. report that isolated pulmonary den-
dritic cells (DCs) produce interleukin (IL)-10 and in-
duce TR1 cells after respiratory exposure to antigen,16
whereas DCs from the gut produce transforming
growth factor (TGF)-β; this may explain why antigen
administered via the gut preferentially induces TH3
regulatory cells.17 Furthermore, in vitro studies using
the intestinal epithelial cell line Caco-2 suggest that
epithelial cells might secrete more TGF-β and α-
tolerogenic cytokines in the physiologically inflamma-
tory environment of the intestine in the presence of
LAB.18 Therefore, LAB may be appropriate for treat-
ment of various disorders, including allergic diseases,
due to their ability to induce Treg cells and activate
these cells through TGF-β production at the mucosal
surface. In the current study, we examined the immu-
nomodulative effect of oral administration of L-92 in
OVA-immunized mice, and studied the underlying
mechanism using splenocytes and cells from Peyer’s
patches (PPs).
METHODS
MICE
Six-week-old male BALBc mice were purchased
from Japan SLC (Hamamatsu, Japan) and acclima-
tized for 1 week before the start of experiments. The
mice were housed in an air-conditioned animal room
at a temperature of 22 ± 1℃ and a humidity of 60 ±
5%, with a 12-hour lightdark cycle under pathogen-
free conditions. They were fed a standard diet (Nor-
san Corporation, Kanagawa, Japan) and allowed free
access to water throughout the experimental period.
Experiments were undertaken in accordance with the
guidelines for the care and use of experimental ani-
mals of the Japanese Association for Laboratory Ani-
mal Science, published in 1987.
BACTERIA
L-92 was obtained from the R&D Center, Calpis Co.
Ltd., Kanagawa, Japan, where the strain was origi-
nally isolated. Bacteria were cultured for 48 hours at
37℃, and the cells were then collected by centrifuga-
tion, washed with sterile distilled water, heat-killed at
100℃, lyophilized, and suspended in phosphate-
buffered saline (PBS).
EXPERIMENTAL SCHEDULE 1 (Fig. 1)
Mice (n = 6 per group) were intraperitoneally injected
with 1 μg of OVA (Ovalbumin; Sigma-Aldrich. Inc.,
St. Louis, USA) absorbed onto 1 mg of alum in 0.1 ml
sterile 0.9% saline in weeks 0, 2, 4, 6 and 8. These
mice were also fed daily with 200 μl of L-92 suspen-
sion (0.2, 1.0 or 5.0 mgdayanimal) in sterile 0.9% sa-
line for 8 weeks from 2 weeks after the 1st immuniza-
tion, using an intragastric stainless steel feeding tube;
control mice did not receive this suspension. Sham
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mice were intraperitoneally injected with 0.1 ml ster-
ile 0.9% saline only in weeks 0, 2, 4, 6 and 8 and also
fed daily with 200 μl of sterile 0.9% saline. Blood was
collected from the orbital cavity under anesthesia
once a week from day 0. Serum samples were pre-
pared by centrifugation at 10000× g at 4℃ for 5 min-
utes, and then frozen at −80℃ until determination of
Ig levels. In week 10, six mice from the control
group, six mice from the sham group, and six mice
from the high-dose L-92 group (5.0 mgdaymouse)
were sacrificed by deep anesthesia, and cells were
subsequently obtained from the spleens and PPs of
these mice.
EXPERIMENTAL SCHEDULE 2
OVA-primed splenocytes were used for in vitro stud-
ies. BALBc mice were injected intraperitoneally with
1 μg of OVA adsorbed onto 1 mg of alum in 0.1 ml
sterile 0.9% saline. Injections were given twice on day
0 and day 14, and mice were sacrificed on day 28 to
obtain splenocytes.
PRODUCTION OF CYTOKINES AND IgS FROM
SPLENOCYTES IN VITRO
Spleens were removed from mice after sacrifice by
deep anesthesia. After lysis of erythrocytes, spleno-
cytes were suspended at a concentration of 2.5 × 106
cellsml in RPMI medium (Invitrogen Corporation,
N.Y., USA) supplemented with 10% fetal calf serum
(FCS; Thermo Trace, Melbourne, Australia) and
penicillinstreptomycin (Invitrogen Corporation).
The splenocytes (2.5 × 106 cellsml) were seeded on
48-well microplates (Nunc, Roskilde, Denmark) and
then stimulated with OVA at a final concentration of
100 μgml at 37℃, in the presence of heat-killed bac-
teria (0.01 to 1 μgml) or in the absence of bacteria.
The effect of oral administration of L-92 on cytokine
and IgE production was tested by culturing the
splenocytes in the same concentration of OVA. Cy-
tokine levels, IgE and OVA-specific IgE levels were
determined after 7 days of the splenocyte cultures, as
previously described.19
PRODUCTION OF TOTAL IgA AND CYTOKINES
FROM PPS IN VITRO
PPs were removed from three mice of each group af-
ter sacrifice by deep anesthesia. Seven to 10 PPs
were obtained from each mouse, and were gently
crushed and filtered through a 40-μm nylon mesh
(BD Bioscience, Bedford, USA). Cells from PPs were
subsequently prepared after organ digestion in RPMI
medium supplemented with collagenase (Roche, Indi-
anapolis, IN, USA) and DNase l (Sigma-Aldrich Co,
Zwijndrecht, The Netherlands) for 60 minutes at 37℃
and pooled. The cells were resuspended at a concen-
tration of 2.5 × 106 cellsml in serum-free medium
consisting of RPMI medium supplemented with Nu-
tridoma SP (1% volvol; Roche) and penicillinstrep-
tomycin. The cells (2.5 × 106 cellsml) were seeded
on 48-well microplates (Nunc, Roskilde, Denmark)
and then stimulated with OVA at a final concentration
of 100 μgml at 37℃ for 72 hours. Cytokine and total
IgA levels produced from the cell cultures were de-
termined after three days, as previously described.20
MEASUREMENT OF CYTOKINES AND IgS
Measurement of IFN-γ, IL-4, TGF-β, IL-10, total IgA,
total IgE and OVA-specific IgE was performed using a
sandwich enzyme-linked immunosorbent assay
(ELISA). Commercial ELISA kits were used for IFN-
γ, IL-4 and TGF-β (Bio Source International, Camar-
illo, CA, USA), IL-10 (R & D, Minneapolis, MN,
USA), and total IgA (Bethyl Laboratories, Inc., Mont-
gomery, TX, USA). OVA-specific IgE and total IgE in
mouse serum and the culture supernatant were meas-
ured using ELISAs, as previously described.21 In
brief, measurement of OVA-specific IgE was per-
formed in flat-bottom 96-well microliter plates (Nunc,
Roskilde, Denmark) coated with anti-mouse IgE (Se-
rotec, Oxford, UK). After blocking with 1% bovine se-
rum albumin (BSA; Sekagaku Kogyo, Tokyo, Japan),
100 μL of diluted sample was added to each well, fol-
lowed by incubation at room temperature for 1 hour.
After washing with PBS containing 0.1% Tween 20 (T-
PBS), 100 μl of diluted biotinylated-OVA was added
to each well and incubated at room temperature for 1
hour. Then, after extensive washing with T-PBS, 100
μl of diluted peroxidase-conjugated streptavidin (Da-
kocytomation, Glostrup, Denmark) was added to
each well. The enzymatic reaction was stopped by ad-
dition of 100 μl of 2 M H2SO4 after incubation at
room temperature for exactly 30 minutes. The optical
densities of the enzymatic reaction solutions were
read using an automatic ELISA plate reader (Multis-
can MS, ver 8; Labsystems Oy, Helsinki, Finland) at
450 nm (reference 690 nm) and analyzed using Delta-
soft 3 (Biometallics Inc., Princeton, NJ, USA). Se-
quentially diluted anti-OVA IgE monoclonal antibody
(mAb; donated by Dr M. Kiniwa, Taiho Pharmaceuti-
cal Co. Ltd., Saitama, Japan) was used to prepare a
standard curve. To measure the total IgE, similar pro-
cedures were carried out using peroxidase-labeled
polyclonal anti-mouse IgE (Nordic Immunological
Laboratories, Tilburg, Netherlands). The detection
limit for IgE and OVA-specific IgE was 1 ngml.
STATISTICAL ANALYSIS
All values are expressed as means ± S.E.M. An un-
paired Student’s t -test (two-tailed) was used to evalu-
ate the significance of the difference between two in-
dependent groups with equal variance, as assessed
using an F test. In all other cases, Welch’s t -test (two-
tailed) was employed. One-way analysis of variance
(ANOVA) and Fisher’s test were used for multiple
comparisons with controls. Values of P < 0.05 were
considered to indicate statistically significant differ-
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Fig. 2 Efect of oral administration of L-92 on OVA-specific IgE production in mice. Blood 
was colected from the orbital cavity once a week from day 0, and the serum level of OVA-
specific IgE was determined by ELISA. #P＜ 0.05 compared with the control group, as-
sessed by ANOVA and Fisher test.
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RESULTS
ORAL ADMINISTRATION OF L-92 SUPPRESSED
ANTI-OVA IgE ANTIBODY PRODUCTION IN VIVO
The time course of serum OVA-specific IgE levels in
OVA-immunized mice is shown in Figure 2. To evalu-
ate the immunomodulative effect of oral administra-
tion of L-92, BALBc mice were injected with OVA at
2-week intervals for 8 weeks. This immunization
schedule resulted in a marked increase in serum
OVA-specific IgE levels (Fig. 2, control). Test groups
were fed heat-killed L-92 (0.2, 1.0 or 5.0 mgday
mouse) during the 8-week period. Serum samples
from all groups were collected weekly. The OVA-
specific IgE levels were significantly lower in mice re-
ceiving L-92, and particularly in those given the high-
est dose (5.0 mgday), compared with the levels in
control mice.
ORAL ADMINISTRATION OF L-92 SUPPRESSED
CYTOKINE PRODUCTION IN SPLENOCYTES IN
VITRO
Upon stimulation with OVA in vitro, splenocytes from
OVA-immunized mice produced IFN-γ, IL-4 and IL-10
(Fig. 3). Each cytokine production was significantly
suppressed in the splenocytes of mice given L-92 at
5.0 mgday, compared with those in control mice
(Fig. 3).
ORAL ADMINISTRATION OF L-92 SUPPRESSED
TOTAL AND OVA-SPECIFIC IgE PRODUCTION
IN SPLENOCYTES IN VITRO
Upon stimulation with OVA in vitro, splenocytes from
OVA-immunized mice produced Igs (total IgE and
OVA-specific IgE) (Fig. 4). Each Igs production was
significantly or completely suppressed in the spleno-
cytes of mice given L-92 at 5.0 mgday, compared
with those in control mice (Fig. 4).
ORAL ADMINISTRATION OF L-92 INDUCED
TGF-β AND TOTAL IgA PRODUCTION IN CELLS
OF PPS IN VITRO
As shown in Figure 5, TGF-β and total IgA production
by cells of PPs from OVA-immunized mice given L-92
at 5.0 mgday was significantly higher than in con-
trol mice.
L-92 INDUCED IFN-γ AND SUPPRESSED IL-4
AND IL-10 PRODUCTION IN CULTURED OVA-
STIMULATED SPLENOCYTES
Isolated splenocytes from OVA-primed BALBc mice
were cultured with the same antigen in the absence
or presence of L-92. As shown in Figure 6, L-92 from
0.01 to 1.0 μgml induced IFN-γ production in a dose-
dependent manner, and the highest dose of L-92 (1.0
μgml) induced significantly higher IFN-γ produc-
tion, compared with control. In contrast, IL-4 and IL-
10 production was significantly suppressed by the
highest dose of L-92 (1.0 μgml), but not in a dose-
dependent manner (lower doses of L-92 did not have
a significant effect). Induction of IFN-γ by L-92
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Fig. 3 Efect of oral administration of L-92 on cytokine (IFN-γ, IL-4 and IL-10) produc-
tion in splenocytes from mice in vitro. As in Figure 1, splenocytes were removed from 
four mice each of the control group, sham group and high-dose L-92 group (5.0 
mg/day). Splenocytes (2.5×106 cels/ml) were stimulated with OVA at a final concen-
tration of 100 μg/ml for 7 days at 37℃, and the cytokine levels in the culture medium 
were then determined by ELISA. #P＜ 0.05 compared with the control group, as-
sessed by unpaired Student’ st-test or Welch’ st-test.
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Fig. 4 Efect of oral administration of L-92 on total-IgE and OVA-specific 
IgE production in splenocytes from mice in vitro. As in Figure 1, spleno-
cytes were removed from four mice each from the control, sham and high-
dose L-92 (5.0 mg/day) groups. Splenocytes (2.5×106 cels/ml) were stimu-
lated with OVA at a final concentration of 100 μg/ml for 7 days at 37℃, and 
then total IgE and OVA-specific IgE levels in the culture medium were deter-
mined by ELISA. #P＜0.05 compared with control group, assessed by un-
paired Student’ st-test or Welch’ st-test.
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Fig. 5 Efect of oral administration of L-92 on TGF-β and total IgA produc-
tions in cels of PPs from OVA-immunized mice in vitro. As in Figure 1, cels 
from PPs were removed from three mice each from the control, sham and 
high-dose L-92 (5.0 mg/day) groups. The cels (2.5×106 cels/ml) from PPs 
were stimulated with OVA at a final concentration of 100 μg/ml for 3 days at 
37℃ before measurement of TGF-β and Total IgA levels using ELISA in 
each case. Sham mice were intraperitonealy injected with 0.1 ml sterile 
0.9% saline only in weeks 0, 2, 4, 6 and 8 and also fed daily with 200 μl of 
sterile 0.9% saline. #P＜ 0.05 compared with control group, assessed by 
unpaired Student’ st-test or Welch’ st-test.
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seemed to be associated with decreased IL-4 and IL-
10 production.
DISCUSSION
L-92 used in this study has been shown to improve
the symptoms of allergic rhinitis patients in a double-
blind placebo-controlled clinical study.22 Therefore, L-
92 is thought to be effective for allergic diseases. To
examine the underlying mechanism, in this study we
observed the effect of direct L-92 administration in
splenocytes of OVA-immunized mice, confirmed the
effect of oral L-92 administration that suppresses the
blood OVA-specific IgE, and determined the mecha-
nism of cytokine and Ig production by splenocytes
and cells of PPs after oral administration of L-92 in
mice.
Addition of heat-killed L-92 and OVA directly to
OVA and alum-immunized splenocytes of mice
caused a significant increase in IFN-γ, a Th1 cytokine,
and a significant decrease in IL-4 and IL-10, which are
both Th2 cytokines (Fig. 6). These in vitro results are
similar to those of previous reports regarding Th1
cell induction by LAB, and L-92 is thought to sup-
press Th2 cells through Th1 cell activation. Cell wall
components of LAB and other probiotics, such as
peptidoglycans and lipoteichoic acid, induce matura-
tion and activation of DCs via toll-like receptor (TLR)
2, as well as producing various proinflammatory cy-
tokines and chemokines.23-25 In addition, immune-
related cytokines, including IL-12, that induce Th1
type responses are produced. Cytosine-guanosine
dinucleotide (CpG) sequence motifs composed of un-
methylated CpG dinucleotides are the immunostimu-
latory components of bacterial DNA.26 Oligodeoxynu-
cleotides (ODNs) containing CpG motifs can directly
or indirectly activate DCs, murine macrophages, B
lymphocytes, natural killer cells, and T lymphocytes.
This action leads to the secretion of various proin-
flammatory cytokines, including IL-6, lL-12, tumor ne-
crosis factor (TNF), and IFN-γ via TLR9, and finally
induces a Th1-biased immune response.27-29 LAB are
known to contain CpG-like immunostimulatory oli-
gonucleotides,30-32 and ligation of TLR2 and TLR9 di-
rectly by some lactobacilli species has also been re-
ported.33,34 Based on these reports, L-92 may be able
to stimulate TLR2 and TLR9 directly, induce a Th1
type response, and suppress the predominance of
OVA-immunized Th2 cells.
Next, we confirmed that oral administration of L-92
suppressed OVA-specific IgE in the blood of OVA-
immunized mice. To examine the underlying mecha-
nism, splenocytes and cells of PP were examined af-
ter oral administration of L-92 to mice. Splenocytes
repeatedly immunized with OVA and alum showed
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Fig. 6 Direct efect of L-92 on OVA-induced cytokine (IFN-γ, IL-4 and Il-
10) production by OVA-immunized splenocytes in vitro. Splenocytes 
(2.5×106 cels/ml) from OVA-immunized BALB/c mice were cultured with 
OVA at a final concentration of 100 μg/ml in the absence (control) or pres-
ence of L-92 (0.01 to 1 μg/ml) for 7 days at 37℃, and the cytokine levels in 
the culture medium were then determined by ELISA. #P＜0.01 compared 
with the control group, assessed by ANOVA and Fisher test.
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high production of IFN-γ, the Th1 cytokine, and the
Th2 cytokines IL-4 and IL-10, by the stimulation of
OVA and significant suppression of the levels of both
Th1 and Th2 cytokines was apparent in splenocytes
from mice given L-92 orally. Coincidently, L-92 ad-
ministration inhibited production of total IgE and
OVA-specific IgE in both in vivo (Fig. 2) and in vitro
(Fig. 4) studies. Based on these data, it appears that
LAB suppress IgE production through a mechanism
that does not involve a shift to Th1-dominant immu-
nity.
Furthermore we examined how oral administration
of LAB affects gut immunity in mice using cells from
PP, a tissue that is often used to examine the gut im-
mune response. Oral administration of L-92 signifi-
cantly increased TGF-β and total IgA in cells from PP.
We suggest that L-92 may induce TH3 regulatory
cells which subsequently spread through the im-
mune system, including to the spleen and modulate
the Th1Th2 balance all over the body.
TGF-β is known to induce an isotype switch of IgA,
and TGF-β secreted from DCs of PP is thought to be
related to increased IgA production in the intestine.
Furthermore, TGF-β secreted from DCs of PP in-
duces oral tolerance through induction of Treg
cells,17,35 and Akbari et al. have suggested that DCs
of the intestine can induce TH3 regulatory cells,
which also produce TGF-β itself and induced by
autocrine.16 TH3 regulatory cells suppress effector T
cell function by production of TGF-β and cell to cell
contact.36
Smits et al. assessed the mechanism of Treg cell
activation in human DCs using Lactobacilli of differ-
ent species.37 L. reuteri and L. casei stimulated
monocyte-derived DCs and facilitated Treg cell acti-
vation, although L. plantarum had no such functions.
L. reuteri and L. casei both interact with the C-type
lectin DC-specific intercellular adhesion molecule 3-
grabbing non-integrin (DC-SIGN), and blocking anti-
bodies for DC-SIGN suppressed Treg cell activation
by these probiotic bacteria. Based on these data,
some species of LAB are thought to exert their func-
tion through DC-SIGN, which in turn is thought to be
involved in Treg cell activation.
We were unable to determine which components
of L-92 induced the significant increase in TGF-β pro-
duction in PPs and which was the cell population con-
cerned with the increase of TGF-β. We are now
studying the change of cell population of PPs and the
specificity of IgA. Orally administered LAB are in-
itially incorporated into M cells in the intestine and
transferred to PP, which plays a leading role in gut
immunity by stimulating DCs. The initial role of the
M cells is uncertain, although Tohno et al. have sug-
gested that TLR2 develops in intestinal M cells of
swine and that TLR2 of M cells may be related to
ligand-specific transcytosis and transport of LAB.38
The initial role of the M cells that may be related to
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ligand-specific transcytosis and transport of LAB
clearly remain to be clarified. Our results suggest
that the immunomodulative effect of oral administra-
tion of L-92 may involve Treg cells, and treatment
based on functions specific to various types of LAB
may therefore be effective for both Th1- and Th2-
mediated diseases such as allergic diseases, autoim-
mune diseases and chronic inflammatory diseases.
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